SQ Innovation
Pioneering subcutaneous drug-device combos for cost-effective at-home heart failure decongestion, reducing hospital burden.
Visit WebsiteKnown For
Novel high-concentration (30mg/mL) room-temperature stable furosemide enabled by Captisol
Key Differentiators
- Novel high-concentration (30mg/mL) room-temperature stable furosemide enabled by Captisol
- cost-effective reusable infusor (48 uses) with disposable cartridge
- enables at-home treatment reducing hospitalization costs
- environmentally considerate design
Overview
SQ Innovation is a biopharmaceutical company developing and commercializing innovative drug-device combinations for subcutaneous delivery to enable at-home treatment of conditions typically requiring hospitalization. Their lead product, Lasix ONYU (furosemide injection 80mg/2.67mL), FDA-approved in October 2025, treats edema in chronic heart failure patients via a reusable infusor and disposable cartridge, offering controlled diuresis comparable to IV without hospital visits. The high-concentration formulation uses Captisol technology under license from Ligand Pharmaceuticals.
Services & Capabilities
- Development and commercialization of subcutaneous drug-device combinations, including Lasix ONYU for at-home heart failure treatment
- distribution partnerships with Cardinal Health SPD and Cencora Specialty Distribution.
Competitive Position
- Novel high-concentration (30mg/mL) room-temperature stable furosemide enabled by Captisol
- cost-effective reusable infusor (48 uses) with disposable cartridge
- enables at-home treatment reducing hospitalization costs
- environmentally considerate design
Recent Developments
FDA approval of Lasix ONYU (Oct 7, 2025); Series B financing closed (Oct 2025); product available for order via Cardinal Health and Cencora (Feb 2026); expanded US operations to Woburn MA (Nov 2025); new board members (Oct 2025)
Client & Partner Ecosystem
Ligand Pharmaceuticals (Captisol license/supply), Cardinal Health Specialty Pharmaceutical Distribution, Cencora Specialty Distribution, Gerresheimer (device collaboration); discussions with IDNs, pay
Technology Platform
Lasix ONYU Infusor (reusable motorized on-body device with prefilled cartridge)
Therapeutic Focus
Cardiology (heart failure)
Target Customers
Healthcare providers (hospitals, IDNs, heart failure programs), pharmacies, payors, patients with chronic heart failure
Sources
Similar Vendors
AeroSafe Global
Pioneering Cold Chain as a Service for reliable, sustainable biopharma delivery worldwide.
Alleguard
Custom EPS foam cold chain packaging protecting pharma products' integrity during transport.
Altor
Engineered cold chain packaging protects pharma biologics and vaccines with certified, sustainable shippers nationwide.
BD / BD Parata
Scalable pharmacy automation powering accurate dispensing, adherence packaging, and workflow for retail, hospital, and LTC pharmacies.
BioCare
Leading specialty pharma distributor delivering life-saving therapies with 24/7 support, rapid distribution, and integrated 3PL for manufacturers.
Cardinal Health
Big 3 distributor aggressively building a multi-specialty pharma services platform through $7.2B in acquisitions — differentiated by Sonexus hub flexibility, nuclear pharmacy moat, and at-Home dire...